Summary
GlobalData's  new report, "Diabetes Care Devices Global Market Briefing to 2016"  provides key data, information and analysis on the global diabetes care  devices market. The report provides market landscape, competitive  landscape and market trends information the diabetes care devices  market. The report provides comprehensive information on the key trends  affecting the market, and key analytical content on the market dynamics.  The report also reviews the competitive landscape and technology  offerings.
This  report is built using data and information sourced from proprietary  databases, primary and secondary research and in-house analysis by  GlobalData's team of industry experts.
Scope
- Key  segments covered include glucose monitoring devices (blood glucose test  strips, blood glucose meters, lancets), and insulin delivery devices  (insulin pens, insulin syringes, insulin pumps). 
-  Annualized global market revenues data from 2002 to 2009, forecast  forward for 7 years to 2016. Company shares data for 2009.
-  Qualitative analysis of key market drivers, and restraints by each  category within diabetes care devices market. 
- The  report also covers information on the leading market players, the  competitive landscape, and the leading pipeline products and  technologies. 
- Key  players covered include Roche, LifeScan, Novo Nordisk, Eli Lilly, Bayer,  and Medtronic.
Reasons  to buy
-  Develop business strategies by understanding the trends and developments  that are driving the diabetes care devices market globally.
-  Design and develop your product development, marketing and sales  strategies.
-  Develop market-entry and market expansion strategies.
-  Exploit in-licensing and out-licensing opportunities by identifying  products, most likely to ensure a robust return.
-  What's the next being thing in the diabetes care devices market  landscape? – Identify, understand and capitalize.
- Make  more informed business decisions from the insightful and in-depth  analysis of the global diabetes care devices market and the factors  shaping it.
1 Table  of contents 2
1.1  List of Tables 4
1.2  List of Figures 5
2  Diabetes – An Overview 6
2.1  Epidemiology 6
3  Device Care Devices – An Overview 8
3.1  Glucose Monitoring Devices 8
3.2  Insulin Delivery Devices 9
4  Global Diabetes Care Devices: Market Characterization 10
4.1  Diabetes Care Devices Market, Global, Revenue ($bn), Historic, 2002-2009  10
4.2  Diabetes Care Devices Market, Global, Revenue ($bn), Forecast, 2009-2016  11
4.3  Glucose Monitoring Devices Market, Global, Revenue ($bn), Historic,  2002–2009 12
4.4  Glucose Monitoring Devices Market, Global, Volume (Units), Historic,  2002–2009 13
4.5  Glucose Monitoring Devices Market, Global, Revenue ($bn), Forecast,  2009–2016 14
4.6  Glucose Monitoring Devices Market, Global, Volume (Units), Forecast,  2009–2016 15
4.7  Insulin Delivery Devices Market, Global, Revenue ($bn), Historic,  2002–2009 16
4.8  Insulin Delivery Devices Market, Global, Volume (Units), Historic,  2002–2009 17
4.9  Insulin Delivery Devices Market, Global Revenue ($bn), Forecast,  2009-2016 18
4.10  Insulin Delivery Devices Market, Global, Volume (Units), Forecast,  2009–20016 19
4.11  Diabetes Care Devices, Market Drivers 20
4.11.1  Patient Convenience to be a 
Major Factor  in Choice of Diabetes Care Devices and will Drive the Market in the Near  Future 20
4.11.2  Advances in the Technology and Introduction of New Generation Devices to  Boost Sales of the Diabetes Care Devices 20
4.11.3  The Advantages Offered by Insulin Pumps to Niche Patient Groups is  Expected to Drive the Insulin Pumps Market 21
4.11.4  Increasing Demand for Glucose Monitoring in Home Care to Drive Growth 21
4.12  Diabetes Care Devices, Market Restraints 21
4.12.1  Low Diagnosis Rate to Restrain Growth of Diabetes Care Devices Market 21
4.12.2  Cultural Preferences among the Elderly for Traditional Remedies may  Negatively Effect Diabetes Care Devices Markets 21
4.12.3  Local Companies to Compete with Big Players in Terms of Distribution and  Price 22
4.12.4  Regular Maintenance, Risk of Infection and Associated Pain Raise Patient  Concerns about the Adoption of Diabetes Care Devices 22
4.12.5  Recent Product Recalls by the US Food and Drug Administration may Lead  to Low Prescription Rates in the Future 22
4.12.6  High Cost to be a Major Deterrent towards Widespread Adoption of Insulin  Pumps 23
5 US  Diabetes Care Devices: Market Characterization 24
5.1  Diabetes Care Devices Market, US, Revenue ($m), Historic, 2002-2009 24
5.2  Diabetes Care Devices Market, US, Volume (units), Historic, 2002-2009 25
5.3  Diabetes Care Devices Market, US, Revenue ($m), Forecast, 2009-2016 26
5.4  Diabetes Care Devices Market, US, Volume (Units), Forecast, 2009-2016 27
6  Diabetes Care Devices Market, Competitive Assessment 28
6.1  Glucose Monitoring Devices Market, Global, Key Company Shares 29
6.2  Insulin Delivery Devices, Global, Key Company Shares 30
6.3  Diabetes Care Devices Market: Key Market Participants 31
6.3.1  F. Hoffmann-La Roche Ltd. 32
6.3.2  LifeScan, Inc. 33
6.3.3  Novo Nordisk A/S 34
6.3.4  Eli Lilly and Company 35
6.3.5  Bayer HealthCare AG 36
6.3.6  Medtronic, Inc. 37
7  Diabetes Care Devices Market, Pipeline Assessment 38
7.1  Diabetes Care Devices, Pipeline Products, by Segment 38
7.2  Profiles of Promising Diabetes Care Devices Under Clinical Development  39
7.2.1  Non Invasive Glucose Monitoring Devices 39
7.2.2  Insulin Pumps 40
7.2.3  Glucose Monitoring Devices 41
8  Appendix 44
8.1  Research Methodology 44
8.2  Secondary Research 45
8.3  Primary Research 45
8.4  Models 45
8.5  Forecasts 46
8.6  Expert Panels 46
8.7  GlobalData Consulting 46
8.8  Contact Us 46
8.9  Disclaimer 46
1.1  List of Tables
Table  1: Diabetes, Major Countries, Estimated Prevalence, 2010 and 2030 7
Table  2: Diabetes Care Devices Market, Global, Revenue ($bn), 2002–2009 10
Table  3: Diabetes Care Devices Market, Global, Revenue ($bn), 2009–2016 11
Table  4: Glucose Monitoring Devices Market, Global, Revenue ($bn), 2002–2009  12
Table  5: Glucose Monitoring Devices Market, Global, Volume (million),  2002–2009 13
Table  6: Glucose Monitoring Devices Market, Global, Revenue ($bn), 2009–2016  14
Table  7: Glucose Monitoring Devices Market, Global, Volume (million),  2009–2016 15
Table  8: Insulin Delivery Devices Market, Global, Revenue ($bn), 2002–2009 16
Table  9: Insulin Delivery Devices Market, Global, Volume (million), 2002–2009  17
Table  10: Insulin Delivery Devices Market, Global, Revenue ($bn), 2009–2016 18
Table  11: Insulin Delivery Devices Market, Global, Volume (million), 2009–2016  19
Table  12: Diabetes Care Devices Market US, Revenue ($m), 2002–2009 24
Table  13: Diabetes Care Devices Market, US, Volume (millions), 2002–2009 25
Table  14: Diabetes Care Devices Market, US, Revenue ($m), 2009–2016 26
Table  15: Diabetes Care Devices Market, US, Volume (Millions), 2009–2016 27
Table  16: Diabetes Care Devices Market, Global, Revenue ($m), 2009 28
Table  17: Glucose Monitoring Devices Market, Global, Revenue ($m), 2009 29
Table  18: Insulin Delivery Devices Market, Global, Revenue ($m), 2009 30
Table  19: Hoffmann-La Roche Ltd., Marketed Products, 2010 32
Table  20: Hoffmann-La Roche Ltd., Pipeline Products, 2010 32
Table  21: LifeScan, Inc. Marketed Products, 2010 33
Table  22: LifeScan, Inc. Pipeline Products, 2010 33
Table  23: Novo Nordisk A/S, Marketed Products, 2010 34
Table  24: Novo Nordisk A/S, Pipeline Products, 2010 34
Table  25: Eli Lilly and Company, Marketed Products, 2010 35
Table  26: Bayer HealthCare AG, Pipeline Products, 2010 36
Table  27: Medtronic, Inc. Marketed Products, 2010 37
Table  28: Medtronic, Inc. Pipeline Products, 2010 37
Table  29: Global Diabetes Care Devices Market, Pipeline, 2010 38
Table  30: EyeSense Blood Glucose Measurement Device, Product Status, 2010 39
Table  31: Easy Check Breathe Glucose Detection System, Product Status, 2010 39
Table  32: SENTRIS-100, Product Status, 2010 40
Table  33: Artificial Pancreas System, Product Status, 2010 40
Table  34: Disposable Insulin Pump System, Product Status, 2010 40
Table  35: Integrated Symbiq/EndoTool System, Product Status, 2010 41
Table  36: Paradigm Veo System, Product Status, 2010 41
Table  37: ACCU-Chek Inform II with RALS Plus Data Management System, Product  Status, 2010 41
Table  38: Pin-SCAN-Non invasive Glucose Meter, Product Status, 2010 42
Table  39: Affinity-based Turbidity Sensor-Glucose Monitoring, Product Status,  2010 42
Table  40: RFID Glucose-Sensing Microchip, Product Status, 2010 42
Table  41: Silicon Micro-Needle, Product Status, 2010 43
1.2  List of Figures
Figure  1: Diabetes, Major Countries, Estimated Prevalence, 2010 and 2030 6
Figure  2: Diabetes Care Devices, Market Segments 8
Figure  3: Diabetes Care Devices Market, Global, Revenue ($bn), 2002–2009 10
Figure  4: Diabetes Care Devices Market, Global, Revenue ($bn), 2009–2016 11
Figure  5: Glucose Monitoring Devices Market, Global, Revenue ($bn), 2002–2009  12
Figure  6: Glucose Monitoring Devices Market, Global, Volume (million),  2002–2009 13
Figure  7: Glucose Monitoring Devices Market, Global, Revenue ($bn), 2009–2016  14
Figure  8: Glucose Monitoring Devices Market, Global, Volume (million),  2009–2016 15
Figure  9: Insulin Delivery Devices Market, Global, Revenue ($bn), 2002–2009 16
Figure  10: Insulin Delivery Devices Market, Global, Volume (million), 2002–2009  17
Figure  11: Insulin Delivery Devices Market, Global, Revenue ($bn), 2009–2016 18
Figure  12: Insulin Delivery Devices Market, Global, Volume (million), 2009–2016  19
Figure  13: Diabetes Care Devices Market US, Revenue ($m), 2002–2009 24
Figure  14: Diabetes Care Devices Market, US, Volume (millions), 2002–2009 25
Figure  15: Diabetes Care Devices Market, US, Revenue ($m), 2009–2016 26
Figure  16: Diabetes Care Devices Market, US, Volume (Millions), 2009–2016 27
Figure  17: Diabetes Care Devices Market, Global, Key Company Share, %, 2009 28
Figure  18: Glucose Monitoring Devices Market, Global, Key Company Share, %,  2009 29
Figure  19: Insulin Delivery Devices Market, Global, Key Company Share, %, 2009  30
Figure  20: Diabetes Care Devices Market, Presence of Key Market Participants by  Segment, 2010 31
Figure  21: Global Diabetes Care Devices Market, Pipeline, 2010 38
Companies  mentioned 
F.  Hoffmann-La Roche Ltd
LifeScan,  Inc.
Novo  Nordisk A/S
Eli  Lilly and Company
Bayer  HealthCare AG
Medtronic,  Inc.